美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lakewood-Amedex Biotherapeutics (Direct Listing)

0.3861

-0.2161-35.89%

盤後：0.39200.0059+1.53%19:49 EDT

成交量：183.08萬

成交額：77.89萬

市值：552.91萬

市盈率：-1.31

高：0.5895

開：0.5630

低：0.3660

收：0.6022

52周最高：9.82

52周最低：0.3660

股本：1,432.04萬

流通股本：470.00萬

量比：5.03

換手率：38.95%

股息：- -

股息率：- -

每股收益(TTM):-0.2950

每股收益(LYR):-0.8399

淨資產收益率：--

總資產收益率：-303.80%

市淨率：-2.81

市盈率(LYR):-0.46

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Lakewood-Amedex Biotherapeutics (Direct Listing)

交易所：

NASDAQ

成立時間：

2006

員工人數：

5

公司地址：

8031 Cooper Creek Blvd.,Suite 103,University Park,Florida,United States

官網：

http://lakewoodamedex.com

郵編：

34201

電話：

傳真：

- -

簡介：

Lakewood-Amedex Biotherapeutics Inc.最初於2006年7月11日在特拉華州註冊成立。該公司是一家私營製藥公司，專註於通過開發其雙磷酸黴素來應對抗菌素耐藥性（AMR）的全球健康危機類抗菌劑。該公司的方法涉及一種新機制，旨在迅速破壞細菌膜的穩定性，這可能會降低耐藥性發展的可能性。他們的先導化合物Nu-3目前正處於治療感染的糖尿病足潰瘍的臨床試驗中，被配製為外用凝膠，可提供快速的抗菌作用和靶向遞送。除了糖尿病足潰瘍，該公司正在探索在治療複雜的尿路感染和肺部感染方面的應用。

董事

名稱

職位

Doug Manion

Chairman of the Board and Director

Kelvin Cooper

Chief Executive Officer,Director and SVP Research & Development

Joseph Tucker

Independent Director

Leonard J. DeRoma

Independent Director

股東

名稱

職位

Kelvin Cooper

Chief Executive Officer,Director and SVP Research & Development

Peter Ceccacci

Chief Financial Officer and VP Administration

Thomas Balzer

Chief Medical Officer and SVP Clinical Development

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/LABT/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","market":"US","secType":"STK","nameCN":"Lakewood-Amedex Biotherapeutics (Direct Listing)","latestPrice":0.3861,"timestamp":1781812800000,"preClose":0.6022,"halted":3,"volume":1830790,"hourTrading":{"tag":"盘后","latestPrice":0.392,"preClose":0.3861,"latestTime":"19:49 EDT","volume":348281,"amount":143405.323819,"timestamp":1781826588480,"change":0.0059,"changeRate":0.015281,"amplitude":0.240611},"delay":0,"changeRate":-0.3588508801062769,"floatShares":4700000,"shares":14320400,"eps":-0.295,"marketStatus":"停牌","change":-0.2161,"latestTime":"06-18 16:00:00 EDT","open":0.563,"high":0.589499,"low":0.366,"amount":778912.2235297001,"amplitude":0.371137,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.295,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"listingDate":1776916800000,"exchange":"NASDAQ","adjPreClose":0.6022,"preHourTrading":{"tag":"盘前","latestPrice":0.572,"preClose":0.614,"latestTime":"09:29 EDT","volume":21539,"amount":12121.554723599998,"timestamp":1781789349300,"change":-0.042,"changeRate":-0.068404,"amplitude":0.031922},"postHourTrading":{"tag":"盘后","latestPrice":0.392,"preClose":0.3861,"latestTime":"19:49 EDT","volume":348281,"amount":143405.323819,"timestamp":1781826588480,"change":0.0059,"changeRate":0.015281,"amplitude":0.240611},"volumeRatio":5.025763079330368},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","floatShares":4700000,"roa":"-303.80%","roe":"--","lyrEps":-0.839872,"volumeRatio":5.025763079330368,"shares":14320400,"dividePrice":0,"high":0.589499,"amplitude":0.371137,"preClose":0.6022,"low":0.366,"week52Low":0.366,"pbRate":"-2.81","week52High":9.82,"institutionHeld":0,"latestPrice":0.3861,"eps":-0.295,"divideRate":0,"volume":1830790,"delay":0,"ttmEps":-0.295,"open":0.563,"prevYearClose":8,"prevWeekClose":0.7674,"prevMonthClose":0.675,"prevQuarterClose":8,"fiveDayClose":0.7228,"twentyDayClose":0.753},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-06-22","symbol":"LABT","defaultRemindTime":1782135000000,"type":"split","dateTimestamp":1782100800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LABT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LABT","date":"2026-06-18","current":-1.308814,"percent":1,"low":-12.282138,"twenty":-11.42611,"median":-2.776507,"eighty":-2.512255,"high":-2.241304,"avg":-5.17349,"sd":3.910892,"marketCap":8623724},"quantilePoints":[{"date":"2026-05-08","current":-12.282138,"twenty":-12.192813,"median":-11.891342,"eighty":-11.604759,"marketCap":47257207},{"date":"2026-05-15","current":-7.294845,"twenty":-12.043939,"median":-11.649421,"eighty":-11.314454,"marketCap":28067917},{"date":"2026-05-22","current":-2.865088,"twenty":-11.850402,"median":-11.258627,"eighty":-3.412052,"marketCap":11023817},{"date":"2026-05-29","current":-2.716586,"twenty":-11.716415,"median":-6.438817,"eighty":-2.758568,"marketCap":10452435},{"date":"2026-06-05","current":-2.512255,"twenty":-11.604759,"median":-3.225364,"eighty":-2.559299,"marketCap":9666247},{"date":"2026-06-12","current":-2.69016,"twenty":-11.537766,"median":-2.813168,"eighty":-2.512255,"marketCap":10350760},{"date":"2026-06-18","current":-2.241304,"twenty":-11.42611,"median":-2.776507,"eighty":-2.512255,"marketCap":8623724}],"updateTime":1781945594050},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1977810588,"yearFounded":2006,"employeeNum":5,"address":"8031 Cooper Creek Blvd.,Suite 103,University Park,Florida,United States","zipCode":"34201","officePhone":"941 225 2515","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://lakewoodamedex.com","stockEarnings":[{"period":"1week","weight":-0.4658},{"period":"1month","weight":-0.5545},{"period":"3month","weight":-0.9517},{"period":"ytd","weight":-0.9517}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Lakewood-Amedex Biotherapeutics Inc.最初於2006年7月11日在特拉華州註冊成立。該公司是一家私營製藥公司，專註於通過開發其雙磷酸黴素來應對抗菌素耐藥性（AMR）的全球健康危機類抗菌劑。該公司的方法涉及一種新機制，旨在迅速破壞細菌膜的穩定性，這可能會降低耐藥性發展的可能性。他們的先導化合物Nu-3目前正處於治療感染的糖尿病足潰瘍的臨床試驗中，被配製為外用凝膠，可提供快速的抗菌作用和靶向遞送。除了糖尿病足潰瘍，該公司正在探索在治療複雜的尿路感染和肺部感染方面的應用。","exchange":"NASDAQ","name":"Lakewood-Amedex Biotherapeutics (Direct Listing)","nameEN":"Lakewood-Amedex Biotherapeutics (Direct Listing)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LABT\",market:\"US\",,,undefined,":{"directors":[{"name":"Doug Manion","position":"Chairman of the Board and Director"},{"name":"Kelvin Cooper","position":"Chief Executive Officer,Director and SVP Research & Development"},{"name":"Joseph Tucker","position":"Independent Director"},{"name":"Leonard J. DeRoma","position":"Independent Director"}],"executives":[{"name":"Kelvin Cooper","position":"Chief Executive Officer,Director and SVP Research & Development"},{"name":"Peter Ceccacci","position":"Chief Financial Officer and VP Administration"},{"name":"Thomas Balzer","position":"Chief Medical Officer and SVP Clinical Development"}]}}}